Fujifilm bet its future on biotech. The payout is still nowhere in sight.
The imaging giant's pivot into drug manufacturing was supposed to write its second act. Investors are still waiting on returns.
By Turki Al-Mutairi·· 3 min
Loading the Newsroom
Curating from trusted global sources…